filmov
tv
Therapeutic antibodies (Part 3): antibody-drug conjugates
Показать описание
This is the third in our three-part series of animations about therapeutic antibodies, this time looking at antibody-drug conjugates. These animations will be part of an upcoming online course by University College London about antibody targeted therapy.
You can find out more about the UCL Antibody-Targeted Therapy online course here:
You can find out more about the UCL Antibody-Targeted Therapy online course here:
0:02:26
Therapeutic antibodies (Part 3): antibody-drug conjugates
0:03:34
Therapeutic antibodies (Part 1): structure & function
0:02:50
Therapeutic antibodies (Part 2): mechanism of action
0:01:41
What Are Monoclonal Antibodies?
0:03:20
How Monoclonal Antibodies Treat Cancer
0:08:42
Antibody therapy
0:16:32
New antibodies and antibody-drug conjugates for B-cell lymphoma
0:01:12
What are therapeutic antibodies?
1:42:59
5th Dr. M K Bhan Memorial Oration
0:02:34
Antibody Drug Conjugates
0:01:44
What are antibody-drug conjugates and how do they work against cancer?
0:20:39
Therapeutic (Monoclonal) Antibodies
0:00:16
What are the common development challenges in therapeutic Monoclonal Antibodies treatment
0:03:54
What Are Antibody Drug Conjugates? - OncTalk Lung 2023
0:43:38
Webinar - Bispecific Antibodies: The Next Generation of Antibody Therapeutics
0:10:03
Antibody Basics: Part 3 - Antibody Formats: Bispecific Antibodies (bsAbs)
0:01:01
Antibody drug conjugates: science and imagination linked by purpose
0:03:14
Anti-Idiotypic Antibodies for Development of CAR T Cell Therapies and Monoclonal Antibody Drugs
0:03:32
Monoclonal Antibodies and its Production
0:02:41
How Do Antibody-drug conjugates ADCs Work?
0:03:36
HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates
0:40:35
Antibody drug development challenges & solutions
0:01:37
Antibody Conference 2018
0:03:05
Antibody Drug Conjugate Treatment in Lung Cancer - OncTalk Lung 2023
Комментарии